Andrew J. Ferrara


Mr. Ferrara began his career with Eli Lilly & Company. In the course of his 20 year tenure with Lilly, he served in a number of business areas in the United States and Europe. During his last four years at Eli Lilly, he was Corporate Director of New Product Planning and Licensing. His line management experience included the management of pharmaceutical operations in France and England. He was also a member of the Board of Lilly Industries in England.

In 1984, Mr. Ferrara co-found Polygen Corporation, a computer software company serving the chemical and pharmaceutical research industries, and initiated a number of research and licensing agreements with academic institutions and major health care corporations in the United States, Europe, and Japan.

Since founding Boston Healthcare in 1993, he has been involved in the development of a number of companies. Presently he serves on the Board of Overseers of the Supreme Judicial Court and of the University of the Sciences in Philadelphia. In addition, Mr. Ferrara chairs the boards of Stemina Biomarker Discovery, Inc. and Inform Genomics, Inc. Mr. Ferrara has been a guest speaker at numerous professional meetings and conferences.